What Will an Unexpected Revenue Boost Mean for This Leading Pharmacy Stock's Bottom Line?
Over the past couple of years, pharmacies have been gravitating toward a core model that provides healthcare services as well as traditional retail offerings. This was recently exhibited by Walgreens Boots Alliance's move to invest $1 billion over four years in building out co-located pharmacy-clinics. Prior to that, we saw CVS Health (NYSE: CVS) acquire Aetna, which had long been known for its medical healthcare management through its insurance services.
With the announcement of its Aetna acquisition, CVS moved closer to its goal of becoming a (self-proclaimed) "premier health innovation company." Now, as the company continues to expand, one competitor is basically handing it a pile of patients and prescriptions. But can this turn into a boost for CVS's bottom line?
Image source: Getty Images.
Source Fool.com
